Clinical trial
E-Selectin Nasal Spray to Prevent Stroke Recurrence
NCT00012454 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Terminated
Key facts
| NCT number | NCT00012454 |
|---|---|
| Title | E-Selectin Nasal Spray to Prevent Stroke Recurrence |
| Official title | Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident, Transient Ischemic Attack |
| Intervention type | Drug |
| Interventions | E-Selectin nasal spray |
| Enrollment | 60 |
| Start date | Mar 1, 2001 |
| Completion | Feb 1, 2004 |
| First posted | Mar 17, 2003 |
| Last update posted | May 4, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: